Editor's Choice
RCT | Insulin Glargine vs. Glimepiride vs. Sitagliptin vs. Liraglutide resulted in similar microvascular outcomes and death rates in patients with Type 2 diabetes not controlled with metformin.
22 Sep, 2022 | 13:20h | UTCGlycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes – New England Journal of Medicine (link to abstract – $ for full-text)
Related Study: Glycemia Reduction in Type 2 Diabetes — Glycemic Outcomes – New England Journal of Medicine
News Release: Two popular diabetes drugs outperformed others in large clinical trial – National Institutes of Health
Secondary analysis of a RCT | Complete revascularization vs. culprit lesion–only PCI for angina-related quality of life in patients with STEMI.
22 Sep, 2022 | 13:17h | UTCComplete Revascularization vs Culprit Lesion–Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial – JAMA Cardiology (link to abstract – $ for full-text)
Related meta-analysis:
Study: Nonculprit-lesion PCI Timing in Patients With ST-Segment Elevation Myocardial Infarction
Studies in patients with cardiogenic shock:
One-Year Outcomes after PCI Strategies in Cardiogenic Shock – New England Journal of Medicine
M-A of the association between new hypoglycemic agents and digestive diseases.
22 Sep, 2022 | 13:16h | UTCMeta-analysis of the association between new hypoglycemic agents and digestive diseases – Medicine
Commentary: Spotlight on digestive risks of newer diabetes drugs – ACP Gastroenterology
RCT | Operative vs. nonoperative treatment of acute unstable chest wall injuries.
22 Sep, 2022 | 13:13h | UTCOperative vs Nonoperative Treatment of Acute Unstable Chest Wall Injuries: A Randomized Clinical Trial – JAMA Surgery (free for a limited period)
Invited commentary: Operative Treatment of Acute Unstable Chest Wall Injuries—Let Us All Take a Deep Breath – JAMA Surgery (free for a limited period)
Author Interview: Operative vs Nonoperative Treatment of Acute Unstable Chest Wall Injuries – JAMA
Related:
RCT | Rib fixation is not beneficial for non–ventilator-dependent chest wall injuries.
Commentary on Twitter
Patients who are on mechanical ventilation may benefit from surgical treatment of unstable chest wall injuries, but non-ventilated patients demonstrated little benefit from surgical intervention. https://t.co/MlQ9qIrKon
— JAMA Surgery (@JAMASurgery) September 21, 2022
A quality improvement study showed that a clinic–based aspirin deimplementation intervention can reduce inappropriate aspirin prescribing and bleeding in patients receiving warfarin for anticoagulation.
22 Sep, 2022 | 13:14h | UTCNews Release: Stopping aspirin when on a blood thinner lowers risk of bleeding, study finds – Michigan Medicine
Commentary on Twitter
An anticoagulation clinic–based #aspirin deimplementation intervention was associated with improved guideline-concordant aspirin use and fewer bleeding complications. https://t.co/kxKFZOdhae #Research
— JAMA Network Open (@JAMANetworkOpen) September 19, 2022
RCT | Helmet noninvasive ventilation no better than usual respiratory support for acute hypoxemic respiratory failure due to COVID-19.
22 Sep, 2022 | 13:11h | UTC
Commentary on Twitter
Helmet noninvasive ventilation did not significantly reduce 28-day mortality vs usual respiratory support among patients with acute hypoxemic respiratory failure due to #COVID19 #pneumonia. https://t.co/LCuuY9UqZA #Research pic.twitter.com/NgdzwCVJ4V
— JAMA (@JAMA_current) September 20, 2022
Understanding post-COVID-19 interstitial lung disease: a new fibroinflammatory disease entity.
22 Sep, 2022 | 13:09h | UTC
Commentary on Twitter
Post #COVID19 interstitial lung disease?
🦠 PC-ILD fibroinflammatory disease
🦠 etiopathogenesis
Identifying risk factors & understanding immunopathomechanisms critical to facilitate early intervention to prevent, slow or arrest lung damage progression.
📎https://t.co/OEM2W9bAEd pic.twitter.com/m4w4qUXl9r— Intensive Care Medicine (@yourICM) September 8, 2022
Study shows that the leading causes of hospitalization of adults with diabetes are changing.
22 Sep, 2022 | 13:08h | UTCCommentaries:
The changing character of diabetes complications – The Lancet Diabetes & Endocrinology (free registration required)
Reasons for hospital admissions in people with type 2 diabetes are changing – MedicalXpress
Pulmonary artery denervation for pulmonary arterial hypertension: a sham-controlled randomized trial.
21 Sep, 2022 | 13:21h | UTCCommentaries:
Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test – TCTMD
Commentary on Twitter
#TCT2022 #JACCINT LBCT SimPub: PADN-CFDA trial included 128 pts w/ #cvPAH. At 6-month follow-up, PADN assoc. w/ a ⬆️ improvement in 6MWD, PVR, RV function, & ⬇️ NT-proBNP. Clinical worsening was ⬇️ & satisfactory clinical response was ⬆️ in the PADN group. https://t.co/3IVaUwCgOT pic.twitter.com/bylhcA4GrQ
— JACC Journals (@JACCJournals) September 18, 2022
Guideline Synopsis | Management of major depressive disorder.
21 Sep, 2022 | 13:23h | UTC
ASCO Guideline | Integrative medicine for pain management in oncology.
21 Sep, 2022 | 13:22h | UTC
Observational study suggests an increased risk of adverse events with the use of perioperative Gabapentin for pain management.
21 Sep, 2022 | 13:20h | UTCPerioperative Gabapentin Use and In-Hospital Adverse Clinical Events Among Older Adults After Major Surgery – JAMA Internal Medicine (free for a limited period)
Invited Commentary: Perioperative Gabapentin Use in Older Adults: Revisiting Multimodal Pain Management – JAMA Internal Medicine (free for a limited period)
Commentary on Twitter
Study suggests that careful risk-benefit assessment is needed before prescribing #gabapentin for perioperative #PainManagement to older patients. https://t.co/GDxupdEjeT #Research
— JAMA Internal Medicine (@JAMAInternalMed) September 19, 2022
M-A | Efficacy and safety of unrestricted visiting policy for critically ill patients.
21 Sep, 2022 | 13:18h | UTC
Commentary on Twitter
https://twitter.com/arianna_gazzato/status/1568138556756860928
RCT | Effects of an exercise program on brain health outcomes for children with overweight or obesity.
21 Sep, 2022 | 13:17h | UTCNews Release: Study finds schoolchildren who exercise perform better academically – University of Granada
Commentary: Exercise Improves Brain Health in Overweight, Obese Youth – HealthDay
Commentary on Twitter
Intelligence, cognitive flexibility and academic performance improved following a 20-week RCT based on aerobic + resistance training among children with overweight or obesity. @ortegaporcel @profithugr @canalUGR and collaborators. #OpenAccess #Research https://t.co/XYddOoO7e7 pic.twitter.com/rZpjJxe3tr
— JAMA Network Open (@JAMANetworkOpen) August 30, 2022
Brief Review | Everything you need to know about deresuscitation.
21 Sep, 2022 | 13:19h | UTCEverything you need to know about deresuscitation – Intensive Care Medicine
Commentary on Twitter
Fluid administration among most common interventions in #ICU… but high potential for harm! Here everything you need to know about deresuscitation
☔️ Why deresuscitation?
☔️ What is it?
☔️ When to start/stop?
☔️ How to deresuscitate?
☔️ So what's next?
🖇️ https://t.co/Qmvm3aOQPA pic.twitter.com/u3ZfNMa2W7— Intensive Care Medicine (@yourICM) August 7, 2022
Long-term follow-up of a RCT | Percutaneous coronary intervention vs. bypass surgery for multivessel coronary artery disease.
20 Sep, 2022 | 13:34h | UTCOriginal Study: Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease – New England Journal of Medicine
Long-term follow-up of a RCT | Outcomes after catheter-based renal artery denervation for resistant hypertension.
20 Sep, 2022 | 13:33h | UTCLong-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial – The Lancet (free registration required)
Commentary: SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss – TCTMD
Original Study: A Controlled Trial of Renal Denervation for Resistant Hypertension – New England Journal of Medicine
RCT | Myopia control effect of repeated low-level red-light therapy in children.
20 Sep, 2022 | 13:31h | UTCCommentary: Repeated Low-Level Red-Light Therapy Reduces Myopia Progression in Children – HCP Live
Brief Review | Source control in the management of sepsis and septic shock.
20 Sep, 2022 | 13:32h | UTCSource control in the management of sepsis and septic shock – Intensive Care Medicine (if the link is paywalled, try this one)
Commentary on Twitter
Source control to eliminate origin of infection, control contamination, restore premorbid anatomy/function in #sepsis & septic shock
🧫 think outside (abdominal) box
🧫 have multidisciplinary approach
🧫 first do NO (additional) harm#FOAMcc on @yourICM
🖇 https://t.co/GrA0oR5lf0 pic.twitter.com/ZyPaFF3qFH— Intensive Care Medicine (@yourICM) September 15, 2022
Preliminary results of a RCT | Once-only colonoscopy vs. two rounds of fecal immunochemical testing 2 years apart for colorectal cancer screening.
20 Sep, 2022 | 13:29h | UTCOnce-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial – The Lancet Gastroenterology & Hepatology (link to abstract – $ for full-text)
Commentary: Two Rounds of FIT vs Single Colonoscopy as a One-time CRC Screening – Medscape (free registration required)
Network M-A | Associations between statins and adverse events in secondary prevention of cardiovascular disease.
20 Sep, 2022 | 13:30h | UTC
RCT | Cerebral embolic protection during transcatheter aortic-valve replacement did not significantly reduce the incidence of periprocedural stroke.
19 Sep, 2022 | 12:49h | UTCCerebral Embolic Protection during Transcatheter Aortic-Valve Replacement – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries:
PROTECTED TAVR: No Less Stroke With Embolic Protection, but Some See Hope – TCTMD
Presumed Clinical Benefits of TAVR Cerebral Protection Remain Unproven — Large trial comes up short in proving a definitive benefit to debris filters – MedPage Today (free registration required)
News Release: Cerebral Embolic Protection During Transcatheter Aortic-Valve Replacement – Cedars-Sinai
Commentary on Twitter
In a randomized trial involving patients with aortic stenosis, the use of a cerebral protection device during TAVR did not decrease the risk of periprocedural stroke, but there were fewer disabling strokes. #TCT2022 https://t.co/wBgNlgmIty pic.twitter.com/EViLG19shX
— NEJM (@NEJM) September 17, 2022
RCT | Multiple doses of prophylactic intravenous antibiotics are no better than a single dose in implant-based breast reconstruction.
19 Sep, 2022 | 12:48h | UTC
Commentary on Twitter
Multiple-dose antibiotic prophylaxis was not superior to a single-dose regimen in preventing surgical site infection and implant removal after implant-based breast reconstruction in this RCT. https://t.co/p7GbNRMPfW #OAResarch
— JAMA Network Open (@JAMANetworkOpen) September 16, 2022
Cohort Study | Seven healthy lifestyle habits linked to reduced risk of dementia in people with diabetes.
19 Sep, 2022 | 12:45h | UTCAssociation of Combined Healthy Lifestyle Factors With Incident Dementia in Patients With Type 2 Diabetes – Neurology (link to abstract – $ for full-text)
News Release: Seven healthy lifestyle habits may reduce dementia risk for people with diabetes – American Academy of Neurology
Commentary: Lifestyle Factors May Cut Dementia Risk in Patients With Diabetes – HealthDay
Cluster RCT | Effects of real-time prescription benefit recommendations on patient out-of-pocket costs.
19 Sep, 2022 | 12:47h | UTCEffects of Real-time Prescription Benefit Recommendations on Patient Out-of-Pocket Costs: A Cluster Randomized Clinical Trial – JAMA Internal Medicine (free for a limited period)
Invited Commentary: Real-time Prescription Benefit Tools—The Promise and Peril – JAMA Internal Medicine (free for a limited period)
Commentary on Twitter
Real-time Prescription Benefits (RTPB) uses patient out-of-pocket (OOP) cost to recommend lower-cost med alternatives to prescribers. In a RCT, RTPB reduced med OOP costs by 11%, though recommendations were only made for a small proportion of orders. https://t.co/xXviGvnbKw pic.twitter.com/naeciB3CDg
— JAMA Internal Medicine (@JAMAInternalMed) September 12, 2022


